COMMUNIQUÉS West-GlobeNewswire

Athenex to Present at the 17th Annual Needham Healthcare Conference
27/03/2018
BUFFALO, N.Y., March 27, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
VANC Pharmaceuticals Appoints Dr. Robert Sindelar to Board of Directors
27/03/2018
VANCOUVER, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“ VANC ” or the “ Company ”) (TSXV:VANC) (OTCQB:NUVPF), a pharmaceutical company focused on the Canadian generic drug, over-the- [...]
Cellectar Granted Seminal U.S. Patent for Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles
27/03/2018
MADISON, Wis., March 27, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]
Tyme Announces First Site Open for its Phase II Trial with SM-88 in Pancreatic Cancer
27/03/2018
NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (“Tyme” or the “Company”) announced today that the first site for the Phase II clinical trial evaluating SM-88 therapy for metastatic [...]
Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
27/03/2018
-- Initiated URIROX-1™, First Phase 3 Trial of ALLN-177 in Enteric Hyperoxaluria; Topline Data Expected in Second Half of 2019 – -- Initiated Phase 2 Trial of ALLN-177 for Patients with Primary Hyperoxaluria or Enteric [...]
Caelum Biosciences Announces Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis
27/03/2018
NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ: FBIO ) Company developing treatments for rare and life-threatening diseases, today announced a new [...]
Tower One Wireless Retains Former Ericsson Telecom Senior Executive
27/03/2018
VANCOUVER, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has retained Mr. John Logiudice, a telecom [...]
Adherium Receives U.S. 510(k) Clearance for Over-the-Counter Sales of its Smartinhaler™ Sensor
27/03/2018
SAN MATEO, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced the U.S. Food and Drug Administration (FDA) has [...]
RedHill Biopharma Announces Two Oral Presentations on BEKINDA® 24 mg for acute gastroenteritis at the SAEM 2018 Annual Meeting
27/03/2018
TEL-AVIV, Israel and RALEIGH, N.C., March 27, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Sorrento Therapeutics Announces Unsecured $120.5M Convertible Note Financing
27/03/2018
SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it has entered into a securities purchase agreement to sell $120.5 million of unsecured [...]
Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad
27/03/2018
MENLO PARK, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio ® [...]
NexImmune Announces Management and Board Appointments
27/03/2018
Scott Carmer appointed Chief Executive Officer Kristi Jones promoted to Chief Operating Officer Alan Roemer appointed Chairman of the Board of Directors GAITHERSBURG, Md., March 27, 2018 (GLOBE NEWSWIRE) -- NexImmune, [...]
Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution
27/03/2018
PETALUMA, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the [...]
Immunovaccine Announces Webcast of R&D Update and Investor Event
27/03/2018
HALIFAX, Nova Scotia, March 27, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced today that it will webcast its ‘R&D Update and Investor [...]
Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution
27/03/2018
RALEIGH, N.C. , March 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, today announced that the company is a founding member of Align [...]
genedrive signs distribution agreement for India with ARKRAY Healthcare pvt Ltd for Genedrive® HCV ID Kit and Genedrive® platform
27/03/2018
For release: 27 March The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication [...]
Recro Pharma Announces Publication of Phase III IV Meloxicam Bunionectomy Data in the Clinical Journal of Pain
27/03/2018
MALVERN, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
Axsome Therapeutics to Host R&D Day with Key Opinion Leaders Focused on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine Dependence
27/03/2018
NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders [...]
Antares Pharma Provides XYOSTED™ Regulatory Update
27/03/2018
EWING, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that the official minutes from the Type A meeting with the U.S. Food and Drug Administration (FDA or the [...]

Pages